| Market Cap | 117.56M | P/E | - | EPS this Y | 87.30% | Ern Qtrly Grth | - |
| Income | -7.52M | Forward P/E | - | EPS next Y | -26.30% | 50D Avg Chg | -2.00% |
| Sales | 5.01M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -48.00% |
| Dividend | N/A | Price/Book | 10.13 | EPS next 5Y | - | 52W High Chg | -93.00% |
| Recommedations | 2.00 | Quick Ratio | 0.77 | Shares Outstanding | 37.46M | 52W Low Chg | 20.00% |
| Insider Own | 79.43% | ROA | -27.72% | Shares Float | - | Beta | -0.55 |
| Inst Own | 0.34% | ROE | -82.56% | Shares Shorted/Prior | 142.63K/165.42K | Price | 3.13 |
| Gross Margin | 8.01% | Profit Margin | -150.28% | Avg. Volume | 14,533 | Target Price | - |
| Oper. Margin | -96.78% | Earnings Date | Oct 2 | Volume | 1,331 | Change | -1.26% |
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
| Maxim Group | Buy | Jan 30, 24 |